Hiromi Hayashi, Makoto Iwasaki, Hideki Nakasone, Reo Tanoshima, Masashi Shimabukuro, Wataru Takeda, Tetsuya Nishida, Shinichi Kako, Shin-Ichiro Fujiwara, Yuta Katayama, et al. Impact of stem cell selection between bone marrow and peripheral blood stem cells for unrelated hematopoietic stem cell transplantation for hematologic malignancies: on behalf of the Donor/Source Working Group of the Japanese Society for Transplantation and Cellular Therapy. Cytotherapy. 2023
Chihiro Yamamoto, Daisuke Minakata, Daizo Yokoyama, Shuka Furuki, Atsuto Noguchi, Shunsuke Koyama, Takashi Oyama, Rui Murahashi, Hirotomo Nakashima, Takashi Ikeda, et al. Cost-effectiveness of anti-BCMA chimeric antigen receptor T cell therapy in relapsed/ refractory multiple myeloma. Transplantation and cellular therapy. 2023
Takashi Nagayama, Shin-Ichiro Fujiwara, Ryutaro Tominaga, Daizo Yokoyama, Atsuto Noguchi, Shuka Furuki, Takashi Oyama, Shunsuke Koyama, Rui Murahashi, Hirotomo Nakashima, et al. Early reversal of the lymphocyte-to-monocyte ratio after allogeneic-hematopoietic stem cell transplantation is associated with reduced relapse and improved prognosis. Clinical transplantation. 2023. e15116
Hiroaki Shimizu, Yuho Najima, Shinichi Kako, Masatsugu Tanaka, Shin-Ichiro Fujiwara, Takehiko Mori, Kensuke Usuki, Moritaka Gotoh, Maki Hagihara, Nobuhiro Tsukada, et al. Clinical significance of late CMV disease in adult patients who underwent allogeneic stem cell transplant. Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy. 2023
Kento Umino, Kaoru Morita, Takashi Ikeda, Shin-Ichiro Kawaguchi, Takashi Nagayama, Shoko Ito, Daisuke Minakata, Masahiro Ashizawa, Chihiro Yamamoto, Kaoru Hatano, et al. Antibody-mediated pathogenesis of chronic GVHD through DBY/HLA class II complexes and induction of a GVL effect. Blood. 2023